Market News

Eagle Global Advisors Trimmed Its Bridgepoint Ed (BPI) Holding; Zimmer Biomet Holdings (ZBH) Shorts Increased By 1.1%

Zimmer Biomet Holdings Incorporated (NYSE:ZBH) had an increase of 1.1% in short interest. ZBH’s SI was 3.96M shares in November as released by FINRA. Its up 1.1% from 3.92M shares previously. With 1.23 million avg volume, 3 days are for Zimmer Biomet Holdings Incorporated (NYSE:ZBH)’s short sellers to cover ZBH’s short positions. The stock increased 0.66% or $0.765 during the last trading session, reaching $117.285. About 999,102 shares traded. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has declined 0.44% since November 30, 2016 and is downtrending. It has underperformed by 17.14% the S&P500.

Eagle Global Advisors Llc decreased Bridgepoint Ed Inc (BPI) stake by 32.47% reported in 2017Q2 SEC filing. Eagle Global Advisors Llc sold 26,962 shares as Bridgepoint Ed Inc (BPI)’s stock rose 39.27%. The Eagle Global Advisors Llc holds 56,076 shares with $828,000 value, down from 83,038 last quarter. Bridgepoint Ed Inc now has $265.19M valuation. The stock decreased 0.66% or $0.06 during the last trading session, reaching $9.07. About 356,025 shares traded or 21.16% up from the average. Bridgepoint Education, Inc. (NYSE:BPI) has risen 69.69% since November 30, 2016 and is uptrending. It has outperformed by 52.99% the S&P500.

Eagle Global Advisors Llc increased Eqt Midstream Partners Lp (NYSE:EQM) stake by 18,036 shares to 441,537 valued at $32.95 million in 2017Q2. It also upped Tc Pipelines Lp (NYSE:TCP) stake by 6,003 shares and now owns 262,455 shares. Cheniere Energy Partners Lp (NYSEMKT:CQP) was raised too.

Investors sentiment increased to 2.07 in Q2 2017. Its up 0.59, from 1.48 in 2017Q1. It improved, as 8 investors sold BPI shares while 22 reduced holdings. 30 funds opened positions while 32 raised stakes. 26.19 million shares or 5.46% more from 24.83 million shares in 2017Q1 were reported. Northern holds 0% or 215,859 shares. Swiss Retail Bank has invested 0% in Bridgepoint Education, Inc. (NYSE:BPI). Nantahala Management Ltd has invested 1.63% in Bridgepoint Education, Inc. (NYSE:BPI). Campbell & Co Investment Adviser reported 0.14% in Bridgepoint Education, Inc. (NYSE:BPI). Rhumbline Advisers, Massachusetts-based fund reported 20,980 shares. Brandes Inv Lp accumulated 12,891 shares. Renaissance Llc, New York-based fund reported 1.51M shares. Tiaa Cref Inv Management Limited Liability Company holds 0% or 163,601 shares. Products Prtnrs Llc holds 38,200 shares or 0.02% of its portfolio. Chicago Equity Ptnrs Limited Liability Company reported 0.07% stake. Warburg Pincus Limited Liability Co holds 9.64M shares or 2.23% of its portfolio. Hillsdale Investment Management owns 65,200 shares or 0.19% of their US portfolio. Spark Invest Limited Liability Company, a New York-based fund reported 37,400 shares. Geode Ltd Llc holds 0% or 137,918 shares. 863,674 were accumulated by D E Shaw And Com.

Analysts await Bridgepoint Education, Inc. (NYSE:BPI) to report earnings on March, 6. They expect $-0.12 earnings per share, down 1,100.00% or $0.11 from last year’s $-0.01 per share. After $0.25 actual earnings per share reported by Bridgepoint Education, Inc. for the previous quarter, Wall Street now forecasts -148.00% negative EPS growth.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $23.75 billion. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental. It has a 33.41 P/E ratio. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Among 30 analysts covering Zimmer Biomet Holdings (NYSE:ZBH), 21 have Buy rating, 2 Sell and 7 Hold. Therefore 70% are positive. Zimmer Biomet Holdings had 76 analyst reports since August 27, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Tuesday, July 11 with “Hold” rating. The rating was maintained by Jefferies on Tuesday, October 10 with “Buy”. As per Thursday, August 11, the company rating was initiated by Suntrust Robinson. Canaccord Genuity maintained it with “Buy” rating and $150 target in Friday, September 4 report. The rating was maintained by Oppenheimer with “Buy” on Friday, July 28. The firm has “Buy” rating by Jefferies given on Tuesday, September 5. RBC Capital Markets maintained Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Sunday, July 23 with “Buy” rating. The firm has “Neutral” rating by Guggenheim given on Thursday, June 9. The company was maintained on Wednesday, July 12 by Needham. On Thursday, July 27 the stock rating was maintained by Piper Jaffray with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *